{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:57:04Z","timestamp":1791161824414,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jhep.2013.11.033","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T14:31:24Z","timestamp":1386340284000},"page":"832-838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Dietary glycotoxins exacerbate progression of experimental fatty liver disease"],"prefix":"10.1016","volume":"60","author":[{"given":"Christopher","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana B.","family":"Herath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Yan","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine M.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.11.033_b0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.11.033_b0010","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/hep.25721","article-title":"Beyond reasonable doubt: who is the culprit in lipotoxicity in NAFLD\/NASH?","volume":"55","author":"Arteel","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.11.033_b0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00726-005-0200-2","article-title":"Protein-bound advanced glycation end products (AGEs) as bioactive amino acid derivatives in foods","volume":"29","author":"Henle","year":"2005","journal-title":"Amino Acids"},{"key":"10.1016\/j.jhep.2013.11.033_b0020","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jada.2004.05.214","article-title":"Advanced glycoxidation end products in commonly consumed foods","volume":"104","author":"Goldberg","year":"2004","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.jhep.2013.11.033_b0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J Mol Med"},{"key":"10.1016\/j.jhep.2013.11.033_b0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s005920070025","article-title":"Serum concentrations of advanced glycation end products are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes","volume":"37","author":"Aso","year":"2000","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jhep.2013.11.033_b0035","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1172\/JCI118889","article-title":"The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis","volume":"98","author":"Miyata","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2013.11.033_b0040","doi-asserted-by":"crossref","first-page":"e35143","DOI":"10.1371\/journal.pone.0035143","article-title":"Effect of dietary advanced glycation end products on mouse liver","volume":"7","author":"Patel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.11.033_b0045","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1440-1746.2006.04225.x","article-title":"Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice","volume":"21","author":"Ekong","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.11.033_b0050","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.20045","article-title":"Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice","volume":"39","author":"Zeng","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.11.033_b0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/jgh.12042","article-title":"Advanced glycation end products augment experimental hepatic fibrosis","volume":"28","author":"Goodwin","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.11.033_b0060","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3748\/wjg.15.5789","article-title":"Role of the receptor for advanced glycation end products in hepatic fibrosis","volume":"15","author":"Lohwasser","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.11.033_b0065","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1440-1746.2007.04943.x","article-title":"Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis","volume":"22","author":"Hyogo","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.11.033_b0070","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0168-8278(03)00456-2","article-title":"Fibrogenic impact of high serum glucose in chronic hepatitis C","volume":"39","author":"Ratziu","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.11.033_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/974681","article-title":"Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy","volume":"2010","author":"Sourris","year":"2010","journal-title":"Exp Diab Res"},{"key":"10.1016\/j.jhep.2013.11.033_b0080","first-page":"11","article-title":"Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy","volume":"4","author":"Sourris","year":"2010","journal-title":"AGE"},{"key":"10.1016\/j.jhep.2013.11.033_b0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1478-3231.2009.02136.x","article-title":"Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model","volume":"30","author":"Francque","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.11.033_b0090","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2013.11.033_b0100","doi-asserted-by":"crossref","first-page":"F763","DOI":"10.1152\/ajprenal.00591.2009","article-title":"Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy","volume":"298","author":"Tan","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jhep.2013.11.033_b0105","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1210\/en.2006-1300","article-title":"Combination therapy with the AGE cross-link breaker, alagebrium and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?","volume":"148","author":"Coughlan","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2013.11.033_b0110","doi-asserted-by":"crossref","first-page":"E323","DOI":"10.1152\/ajpendo.00024.2008","article-title":"Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs","volume":"295","author":"Tikellis","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhep.2013.11.033_b0115","doi-asserted-by":"crossref","first-page":"G137","DOI":"10.1152\/ajpgi.00080.2005","article-title":"Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis","volume":"290","author":"Patella","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2013.11.033_b0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2009.12.007","article-title":"Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells","volume":"52","author":"Guimar\u00e3es","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.11.033_b0125","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.11.033_b0130","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1096\/fj.11-192997","article-title":"Opposing roles of RAGE and Myd88 signaling in extensive liver resection","volume":"26","author":"Zeng","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2013.11.033_b0135","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/db07-1119","article-title":"Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-\u03b1\u2013dependent pathway","volume":"57","author":"Thallas-Bonke","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2013.11.033_b0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mam.2007.09.016","article-title":"4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases","volume":"29","author":"Poli","year":"2008","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jhep.2013.11.033_b0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","author":"Rinella","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.11.033_b0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.diabres.2004.09.004","article-title":"Advanced glycation end products\u2014role in pathology of diabetic complications","volume":"67","author":"Ahmed","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jhep.2013.11.033_b0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00535-007-2152-7","article-title":"Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells","volume":"43","author":"Iwamoto","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.11.033_b0160","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2013.11.033_b0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/jhep.2003.50316","article-title":"Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E","volume":"38","author":"Kugelmas","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.11.033_b0170","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2741\/reeves","article-title":"Activation of hepatic stellate cells-a key issue in liver fibrosis","volume":"7","author":"Reeves","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.jhep.2013.11.033_b0175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00535-007-2152-7","article-title":"Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells","volume":"43","author":"Iwamoto","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.11.033_b0180","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2174\/138161208784139701","article-title":"Advanced glycation end products (AGEs) and their involvement in liver disease","volume":"14","author":"Hyogo","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jhep.2013.11.033_b0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10408690590900117","article-title":"Coordinate contribution of lipid oxidation and Maillard reaction to the nonenzymatic food browning","volume":"45","author":"Zamora","year":"2005","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.jhep.2013.11.033_b0195","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/gerona\/62.4.427","article-title":"Circulating glycotoxins and dietary advanced glycation end products: two links to inflammatory response, oxidative stress, and aging","volume":"62","author":"Uribarri","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jhep.2013.11.033_b0200","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1016\/j.jada.2010.03.018","article-title":"Advanced glycation end products in foods and a practical guide to their reduction in the diet","volume":"110","author":"Uribarri","year":"2010","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.jhep.2013.11.033_b0205","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ajcn.81.2.341","article-title":"Origins and evolution of the Western diet: health implications for the 21st century","volume":"81","author":"Cordain","year":"2005","journal-title":"Am J Clin Nutr"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813008362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813008362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T12:16:15Z","timestamp":1564920975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813008362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0168827813008362"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.11.033","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dietary glycotoxins exacerbate progression of experimental fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2013.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}